您的位置: 首页 > 农业专利 > 详情页

Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarate
专利权人:
Teva Pharmaceutical Industries Ltd.
发明人:
Kaye, Joel Flaxman
申请号:
AU2018200065
公开号:
AU2018200065A1
申请日:
2018.01.04
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2018200065A120180201.pdf#####Abstract The invention provides a method of treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof, and an amount of dimethyl fumarate (DMF) or pharmaceutically acceptable salt thereof, wherein the amounts when taken together are effective to treat the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充